| 6/27/2016 | PP | RegeneRx negotiates $1.75 million private placement of common shares
|
| 3/11/2014 | PP | RegeneRx to conduct $2.35 million private placement of common shares
|
| 1/9/2014 | PP | RegeneRx takes in $55,000 via private placement of convertible notes
|
| 9/17/2013 | PP | RegeneRx raises $321,000 via private placement of convertible notes
|
| 7/11/2013 | PP | RegeneRx takes in $100,000 via private placement of convertible notes
|
| 4/3/2013 | PP | RegeneRx raises $225,000 via private placement of convertible notes
|
| 4/1/2013 | PP | RegeneRx Biopharmaceuticals places $225,000 5% convertibles due 2018
|
| 10/24/2012 | PP | RegeneRx takes in $300,000 via private placement of convertible notes
|
| 1/7/2011 | PP | RegeneRx Biopharmaceuticals heralds $11 million equity investment
|
| 10/1/2009 | PP | New Issue: RegeneRx gives details on $3.7 million direct offering of common stock
|
| 9/30/2009 | PP | New Issue: RegeneRx aims to raise $3.7 million in direct offering of common stock
|
| 12/11/2008 | PP | New Issue: RegeneRx concludes $3 million private placement of stock
|
| 12/11/2008 | PP | Market Commentary: Apollo's $15 million bridge keeps project on time; Hecla, DMC plan deals; RegeneRx raises
|
| 2/27/2008 | PP | New Issue: RegeneRx secures $5 million from placement of stock, warrants
|
| 2/27/2008 | PP | Market Commentary: Coda secures $12 million from convertibles; RegeneRx sells to existing investors; Atlas to raise C$3 million
|
| 1/7/2008 | PP | RegeneRx extends expiration dates of warrants sold in 2005
|
| 12/19/2006 | PP | Market Commentary: Neurogen to seal $40 million direct sale of stock; Third Wave caps $14.8 million PIPE
|
| 12/18/2006 | PP | New Issue: RegeneRx Biopharmaceuticals raises $9.55 million from stock sale
|
| 12/18/2006 | PP | Market Commentary: Smith & Wesson arms itself with $80 million from note sale; Youbet.com gambles on $20.15 million PIPE
|
| 3/6/2006 | PP | Market Commentary: TRC wraps $20 million stock deal; Metalline Mining leads influx of resources offerings
|
| 3/6/2006 | BTPP | New Issue: Regenerx Biopharmaceuticals plans $7.28 million direct placement of shares
|
| 6/23/2005 | PP | Market Commentary: PIPE volume limited to mostly small deals, sell-sider say; Modtech raises $11.7 million in stock offering
|
| 6/23/2005 | BTPP | New Issue: RegeneRx closes $4.99 million private placement of stock
|
| 1/10/2005 | PP | Market Commentary: Private placement volume up on better stocks; RegeneRx closes $5.86 million deal
|
| 1/10/2005 | PP | New Issue: RegeneRx closes private placement for $5.86 million
|
| 1/3/2005 | PP | New Issue: RegeneRx closes first tranche of private placement for $5.86 million
|
| 1/3/2005 | PP | Market Commentary: Oil, stocks cause private placement volume to sag; Critical Path closes $18 million deal
|
